Most people's path to a GLP-1 medication runs through the same handful of decisions: who prescribes it, whether insurance will cover it, and how you fill it. This guide takes those steps in order and points you to what to do when one doesn't go your way.
The workflow at a glance
%%{init: {'theme':'base', 'themeVariables': { 'primaryColor':'#6366f1','primaryTextColor':'#ffffff','primaryBorderColor':'#4338ca','lineColor':'#94a3b8','secondaryColor':'#10b981','secondaryTextColor':'#ffffff','secondaryBorderColor':'#047857','tertiaryColor':'#fef3c7','tertiaryTextColor':'#78350f','tertiaryBorderColor':'#d97706'}}}%%
flowchart TD
A([Considering a GLP-1 medication]) --> B[Step 1: Talk to your primary care provider]
B --> C{Does your PCP prescribe GLP-1s directly?}
C -->|Yes| D[PCP evaluates you and starts prescribing]
C -->|No| E[Referral to a weight management / obesity medicine specialist]
E --> F[Specialist evaluates you and starts prescribing]
D --> G[Step 2: Verify your insurance coverage]
F --> G
G --> H{Covered at an affordable cost?}
H -->|Yes| I[Step 3a: Fill via retail or specialty pharmacy]
H -->|No| J[Step 3b: Explore other access paths]
J --> J1[Manufacturer savings card or direct-pay pricing]
J --> J2[Patient assistance program]
J --> J3[Compounded medication via licensed telehealth, narrowed since 2025]
J --> J4[Appeal the denial]
I --> K[Step 4: Decide: branded or compounded?]
J1 --> K
J2 --> K
J3 --> K
J4 --> K
K --> L([Step 5: Begin titration under your prescriber's guidance])
classDef startEnd fill:#6366f1,stroke:#4338ca,color:#ffffff,stroke-width:2px
classDef decision fill:#f59e0b,stroke:#d97706,color:#78350f,stroke-width:2px
classDef process fill:#10b981,stroke:#047857,color:#ffffff,stroke-width:2px
classDef altpath fill:#f1f5f9,stroke:#94a3b8,color:#334155,stroke-width:1px
class A,L startEnd
class C,H decision
class B,D,E,F,G,I,K process
class J,J1,J2,J3,J4 altpathStep 1: Start with primary care, and expect a possible referral
Most people first talk about a GLP-1 medication with their primary care provider (PCP). Our discussion guide on talking to your doctor about GLP-1 medications helps you prepare for that appointment. From there, one of two things usually happens.
Your PCP may evaluate you and prescribe directly. Many primary care providers are comfortable prescribing GLP-1 medications themselves, particularly for patients with type 2 diabetes or straightforward weight-management cases.
Or your PCP may refer you to a weight management or obesity medicine specialist. That's common when your medical history is more complex, when your PCP prefers a specialist to manage titration and side effects, or simply because of how that PCP practices. A referral is a normal part of the process for many patients, and specialists often have more experience with the full range of GLP-1 medications and dosing details.
Either way, the next step is the same: an evaluation of your medical history, BMI, and related conditions, and, if appropriate, a prescription.
Step 2: Check your insurance coverage before you assume a cost
Once you have a prescription, or are close to one, check your coverage before you're standing at the pharmacy counter. Our guides on checking whether your formulary covers GLP-1 medications and understanding insurance coverage for GLP-1 medications cover formulary tiers, prior authorization, step therapy, and why the diagnosis on your prescription (diabetes or weight management) affects coverage.
Step 3: If coverage falls short
A denial or an unaffordable copay still leaves you several options:
- Manufacturer savings cards. If your plan covers the drug but your copay is high, a savings card can cut what you pay at the counter. See our guide to manufacturer savings cards.
- Manufacturer direct-pay. If your plan doesn't cover the drug at all, LillyDirect and NovoCare sell certain brand products to cash-paying patients at a set price. See our LillyDirect vs. NovoCare comparison.
- Patient assistance programs. These free-medication programs are for uninsured or underinsured patients who meet income limits, and as of September 2026 they cover only some diabetes GLP-1s. See our guide to applying for a patient assistance program.
- An appeal. See what a successful insurance appeal campaign looks like and how to write an effective appeal letter.
- Compounded medication through a licensed telehealth provider or pharmacy. This used to be a common path when brand-name coverage wasn't available or affordable. FDA declared the tirzepatide shortage resolved in late 2024 and the semaglutide shortage resolved in February 2025, and the enforcement discretion that had allowed mass compounding ended in 2025, so this lane is now much narrower. Our pharmacy-sources guide covers where it stands.
Step 4: Branded or compounded
Branded GLP-1s now come in more forms than the pen. As of September 2026, Zepbound is sold as a single-dose vial as well as pens, and there are three GLP-1 pills: Wegovy tablets for weight management, Ozempic tablets for type 2 diabetes (on sale since May 2026), and Foundayo (orforglipron), approved in April 2026. Compounded products, by contrast, often come as a vial you draw from with a syringe. Make this choice on purpose, not by clicking the first ad or search result.
| Branded medication | Compounded medication | |
|---|---|---|
| Regulatory status | FDA-approved, standardized manufacturing | Not FDA-approved as a standalone product. Legality depends on shortage status and pharmacy licensing, and with both shortages declared resolved in 2024–2025, only a narrow individualized lane remains |
| Form | Prefilled pen (see pen types and injection technique), Zepbound single-dose vial, or a daily tablet (Wegovy, Ozempic, Foundayo) | Often a vial and syringe, with doses you measure yourself (see compounded dosing) |
| Cost | Insurance or a savings card may cover it. Brand cash prices as of September 2026 include Zepbound vial or KwikPen at $299–$449 a month, Wegovy pen from $199 for introductory doses then $349, and Wegovy or Ozempic tablets and Foundayo from $149 | Prices vary by pharmacy and telehealth plan. Compare against brand cash prices before assuming compounded is cheaper |
| Quality assurance | Manufacturer-standardized concentration and purity | Varies by pharmacy. Verify GMP compliance and licensing directly; see talking to a pharmacist about compounded medications |
| How you get it | Prescriber plus a retail, specialty, or manufacturer pharmacy | Often through telehealth platforms partnered with a compounding pharmacy |
| Main risk to manage | Cost and insurance navigation | Sourcing legitimacy; see the compounding pharmacy debate |
If you're considering telehealth plus a compounded medication, the first thing to settle is whether that specific telehealth provider and pharmacy are legitimate and licensed. A low price doesn't answer that. Our guide on talking to a pharmacist about compounded medications and sourcing lists the questions to ask before you commit to a source.
Step 5: Starting treatment
Once you have a prescription and a source, treatment starts with titration: a low dose that steps up over weeks. Our guide on how titration schedules work explains what to expect in the first weeks and months.
This is general education, not medical advice. Decisions about your access, coverage, and treatment belong with you and your care team.